Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionAbacus Planning Group, Inc.
Latest Disclosed Ownership40,037 shares
Latest Disclosed Value $ 3,206,163
Abacus Planning Group, Inc. reports 0.02% decrease in ownership of EW / Edwards Lifesciences Corporation

On April 7, 2026 - Abacus Planning Group, Inc. filed a 13F-HR form disclosing ownership of 40,037 shares of Edwards Lifesciences Corporation (MX:EW) valued at $3,206,163 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 16, 2026 disclosing 40,047 shares of Edwards Lifesciences Corporation. This represents a change in shares of -0.02% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 40,037 -10 -0.02 3,206 -6.09 0.4316
2026-01-16 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 40,047 -124 -0.31 3,414 9.28 0.4544
2025-10-22 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 40,171 0 0.00 3,124 -0.54 0.4310
2025-07-21 2025-06-30 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 40,171 -24 -0.06 3,142 7.83 0.4672
2025-04-14 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 40,195 -12 -0.03 2,913 -2.12 0.5103
2025-02-03 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 40,207 140 0.35 2,977 12.56 0.5235
2024-10-02 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 40,067 629 1.59 2,644 -27.40 0.4726
2024-07-31 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 39,438 19 0.05 3,643 -3.29 0.7066
2024-04-12 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 39,419 0 0.00 3,767 25.32 0.7362
2024-01-19 2023-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 39,419 -78 -0.20 3,006 9.83 0.6338
2023-10-11 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 39,497 78 0.20 2,736 -26.41 0.6659
2023-07-07 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 39,419 -425 -1.07 3,718 12.80 0.8996
2023-04-18 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 39,844 375 0.95 3,296 11.96 0.8494
2023-01-19 2022-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 39,469 -603 -1.50 2,945 -11.08 0.8053
2022-10-19 2022-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 40,072 0 0.00 3,311 -13.10 0.9996
2022-07-18 2022-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 40,072 0 0.00 3,810 -19.23 1.1226
2022-04-13 2022-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 40,072 0 0.00 4,717 -9.13 1.2698
2022-01-18 2021-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 40,072 0 0.00 5,191 14.41 1.3862
2021-10-19 2021-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 40,072 -155 -0.39 4,537 8.91 1.4445
2021-07-20 2021-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 40,227 -1,490 -3.57 4,166 19.40 1.2721
2021-04-27 2021-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 41,717 -1,660 -3.83 3,489 -11.83 1.1164
2021-02-01 2020-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 43,377 0 0.00 3,957 14.30 1.2216
2020-11-03 2020-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 43,377 -570 -1.30 3,462 13.99 1.2627
2020-08-11 2020-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 43,947 29,276 199.55 3,037 9.76 1.2364
2020-04-30 2020-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 14,671 -163 -1.10 2,767 -20.05 1.3598
2020-01-30 2019-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 14,834 -82 -0.55 3,461 5.52 1.5896
2019-11-01 2019-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 14,916 433 2.99 3,280 22.57 1.6252
2019-08-12 2019-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 14,483 -747 -4.90 2,676 -8.17 1.6075
2019-04-25 2019-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 15,230 -232 -1.50 2,914 23.06 1.8215
2019-02-15 2018-12-31 13F/A-2 EDWARDS LIFESCIENCES COM 28176E108 15,462 -130 -0.83 2,368 -12.75 1.7954
2019-02-13 2018-12-31 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 9,585 -5,877 836 0.6339
2019-01-25 2018-12-31 13F ENTERPRISE PRODS PARTNER COM 28176E108 15,462 -130 2,368
2018-10-31 2018-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 15,592 0 0.00 2,714 19.61 1.8207
2018-07-26 2018-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 15,592 -585 -3.62 2,269 0.53 1.7044
2018-05-04 2018-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 16,177 -67 -0.41 2,257 23.27 1.8397
2018-03-06 2017-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 16,244 16,244 1,831 1.8561
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.